Who Paid My Doc
Viva XT CRT-D
Device Implantable Cardioverter Defibrillators (ICDs)
PDI 00643169720312
General payments
$3,321
Research payments
$2,797,657
Through program year 2024, $3,321 in general payments and $2,797,657 in research payments were reported against Viva XT CRT-D (Implantable Cardioverter Defibrillators (ICDs)).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $15,703 | 2 |
| 2023 | General | $2,449 | 13 |
| 2023 | Research | $278,912 | 100 |
| 2022 | General | $872 | 6 |
| 2022 | Research | $2,503,042 | 520 |
Breakdown
The top 5 of 13 recipients; each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 10 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
19 general · 622 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.